Copyright
©The Author(s) 2020.
World J Clin Oncol. Aug 24, 2020; 11(8): 510-527
Published online Aug 24, 2020. doi: 10.5306/wjco.v11.i8.510
Published online Aug 24, 2020. doi: 10.5306/wjco.v11.i8.510
Table 3 Stereotactic body radiotherapy schemes for oligometastatic non-small cell lung cancer
| Localisation | Fractions/Total dose |
| Brain | 1 fx: 18-24 Gy; 3 fx: 24-27 Gy; 5 fx: 25-35 Gy |
| Lung | 3 fx: 54 Gy; 4 fx: 48 Gy; 5 fx: 50-60 Gy |
| Adrenal gland | 3 fx: 36-45 Gy; 5 fx: 40-50 Gy |
| Liver | 1 fx: 24-26 Gy; 3 fx: 45-60 Gy; 5 fx: 40-50 Gy; 8 fx: 60 Gy |
| Bone (spinal column included) | 1 fx: 16-24 Gy; 3 fx: 27-30 Gy; 5 fx: 30-40 Gy |
- Citation: Couñago F, Navarro-Martin A, Luna J, Rodríguez de Dios N, Rodríguez A, Casas F, García R, Gómez-Caamaño A, Contreras J, Serrano J. GOECP/SEOR clinical recommendations for lung cancer radiotherapy during the COVID-19 pandemic. World J Clin Oncol 2020; 11(8): 510-527
- URL: https://www.wjgnet.com/2218-4333/full/v11/i8/510.htm
- DOI: https://dx.doi.org/10.5306/wjco.v11.i8.510